洋地黄制剂和β受体阻滞剂治疗房颤的Meta分析  

Effectiveness Meta-analysis of digitalis and β-blocker for atrial fibrillation

作　　者：邵晶晶[1] 孙勇新[2] 杜进香 

机构地区：[1]复旦大学卫生发展战略研究中心,上海200032 [2]复旦大学附属中山医院心脏外科,上海200032 [3]山东省潍坊市市直机关医院,山东潍坊261041

出　　处：《山东大学学报（医学版）》2004年第6期708-710,共3页Journal of Shandong University:Health Sciences

摘　　要：目的:比较洋地黄制剂、β受体阻滞剂和两药合用三种方法治疗房颤的效果。方法:采用荟萃分析方法,检索并筛选相关文献,比较三种用药方法治疗前后静息心率的变化,以此推断其疗效。结果:三种用药方法均可控制房颤后心室率,两药合用疗效尤为显著,其作用要强于单独使用洋地黄制剂或β受体阻滞剂。结论:两药合用疗效明显,是治疗房颤、控制心室率较为理想的方法。Objective: To compare the effectiveness of digitalis, β-blocker, and their combination in controlling atrial fibrillation by Meta-analysis. Methods: Data about the therapeutic effectiveness of three methods were collected and selected. Meta-analysis was performed to compare the effectiveness on ventricular rate in atrial fibrillation. Results: All of the three medicine administrations, especially the combination of digitalis and β-blocker, were effective in controlling ventricular rate of atrial fibrillation. Conclusion: The combination of the two medicine administration is ideal in controlling ventricular rate of atrial fibrillation.

关 键 词：心房颤动 META分析 洋地黄 Β受体阻滞剂 

分 类 号：R541.75[医药卫生—心血管疾病]